Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).

NCT: NCT07426809 · RECRUITING

NCT IDNCT07426809
StatusRECRUITING
Start Date2025-12-18
Completion2028-12-31

Brief Summary

Breast-conserving surgery is commonly performed to remove early-stage breast cancer or ductal carcinoma in situ (DCIS). During surgery, the goal is to completely remove the tumour with a clear margin of normal tissue around it. If cancer cells are found at the edge of the removed tissue (a "positive margin"), patients may need a second operation (re-excision). Re-excision can delay further treatment, increase patient anxiety, and increase healthcare costs. To help assess margins during surgery, surgeons use specimen imaging. Standard practice involves two-dimensional (2D) specimen mammography, usually performed in the radiology department. This requires temporary transfer of the specimen out of the operating theatre and provides limited depth information. The MOZART study is evaluating whether three-dimensional (3D) digital breast tomosynthesis, performed in the operating theatre using the Mozart system, improves margin assessment compared to standard 2D specimen mammography. Patients undergoing breast-conserving surgery at Beaumont Hospital who agree to participate will be randomly assigned (like flipping a coin) to one of two groups: Standard 2D specimen mammography (current standard practice), or 3D digital breast tomosynthesis performed in theatre. In both groups, the operating surgeon will review the images during surgery and decide whether additional tissue needs to be removed. The final margin status will be determined by routine laboratory analysis after surgery. The main goal of this study is to compare the rate of positive margins between the two imaging methods. Other outcomes include the need for additional surgery, operating time, and overall workflow efficiency. The results of this study may help determine whether intraoperative 3D imaging improves surgical outcomes and reduces the need for re-excision in patients undergoing breast-conserving surgery.

Frequently Asked Questions

What is Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).?

Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). is a clinical trial registered under NCT07426809. Current status: RECRUITING.

What is the status of NCT07426809?

The current status of NCT07426809 (Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).) is: RECRUITING.

When did Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). start?

Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). started on 2025-12-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.